Trial Profile
A phase II study of MORAb-022 in mild-to-moderate RA patients
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Dec 2015
Price :
$35
*
At a glance
- Drugs Gimsilumab (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- 09 Dec 2015 New trial record